Why Phibro Animal Health (PAHC) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
PAHC or BSX: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two stocks offers value investors a better bang for their buck right now?
Why Phibro Animal Health (PAHC) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Phibro Animal Health Corporation (PAHC) Q1 2026 Earnings Call Transcript
Phibro Animal Health Corporation ( PAHC ) Q1 2026 Earnings Call November 6, 2025 9:00 AM EST Company Participants Glenn David - Chief Financial Officer Jack Bendheim - Chairman, President & CEO Larry Miller - Chief Operating Officer Daniel Bendheim - Executive VP of Corporate Strategy & Director Conference Call Participants Erin Wilson Wright - Morgan Stanley, Research Division Ekaterina Knyazkova - JPMorgan Chase & Co, Research Division Navann Ty Dietschi - BNP Paribas, Research Division Presentation Operator Hello, and thank you for standing by. Welcome to the Phibro Animal Health Corporation First Quarter 2026 Webcast and Conference Call.
Is Phibro (PAHC) a Solid Growth Stock? 3 Reasons to Think "Yes"
Phibro (PAHC) is well positioned to outperform the market, as it exhibits above-average growth in financials.
PAHC vs. BSX: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two companies is the best option for those looking for undervalued stocks?
Phibro Animal Health Corporation (PAHC) Hits Fresh High: Is There Still Room to Run?
Phibro (PAHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
PAHC or BSX: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two companies is the best option for those looking for undervalued stocks?
Phibro Animal Health Corporation (PAHC) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
Phibro Animal Health Corporation (NASDAQ:PAHC ) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 12:20 PM EDT Company Participants Glenn David - Chief Financial Officer Conference Call Participants Erin Wilson Wright - Morgan Stanley, Research Division Presentation Erin Wilson Wright Equity Analyst Hi. Good afternoon, everyone.
Phibro Animal Health Corporation (PAHC) Q4 2025 Earnings Conference Call Transcript
Phibro Animal Health Corporation (NASDAQ:PAHC ) Q4 2025 Earnings Conference August 28, 2025 9:00 AM ET Company Participants Daniel M. Bendheim - Executive VP of Corporate Strategy & Director Glenn C.
Here's Why Phibro Animal Health (PAHC) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
PAHC vs. BSX: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two stocks is more attractive to value investors?
